Abstract
Conclusion
N4-n-valeryl-, N4-n-caproyl-, and N4-n-heptanoyl-sulfanilylhydroxamide possess approximately the same therapeutic activity as siilfanilamide against sepsis in mice produced by 2 strains of hemolytic streptococci and one strain of Type II pneumococci.
Get full access to this article
View all access options for this article.